← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vlp Biotech, Inc.
San Diego, CA
$9,613,783
Total funding
8
Grants
Funding over time
peak $1.9M · FY2007–21$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$9,613,783 · 8
By mechanism
R44$6,909,183 · 2
R43$1,648,654 · 4
R41$1,055,946 · 2
Investigators at Vlp Biotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
An epitope-focused nanoparticle vaccine for anthrax$998,145
R44 · FY2020 · AI
An epitope-focused nanoparticle vaccine for anthrax$983,698
R44 · FY2021 · AI
A Therapeutic Vaccine for Chronic Hepatitis B$982,569
R44 · FY2013 · AI
A Therapeutic Vaccine for Chronic Hepatitis B$981,428
R44 · FY2014 · AI
A Therapeutic Vaccine for Chronic Hepatitis B$926,325
R44 · FY2012 · AI
A therapeutic vaccine for chronic hepatitis B$878,409
R44 · FY2019 · AI
A therapeutic vaccine for chronic hepatitis B$858,609
R44 · FY2020 · AI
An epitope-focused nanoparticle vaccine for anthrax$300,000
R44 · FY2019 · AI
A Therapeutic Vaccine for Chronic Hepatitis B$300,000
R43 · FY2011 · AI
Development of a Proplylactic HCV Vaccine$300,000
R43 · FY2007 · AI
Development of a Proplylactic HCV Vaccine$300,000
R43 · FY2008 · AI
A Therapeutic Vaccine for Chronic Hepatitis B$299,513
R43 · FY2010 · AI
An epitope-focused nanoparticle vaccine for MRSA and biodefense$273,748
R41 · FY2016 · AI
An epitope-focused nanoparticle vaccine for MRSA and biodefense$272,381
R41 · FY2017 · AI
A molecularly targeted pre- and post-exposure vaccine for anthrax$260,205
R41 · FY2014 · AI
A molecularly targeted pre- and post-exposure vaccine for anthrax$249,612
R41 · FY2015 · AI
A method to determine mRNA isoform frequencies using novel primer generators$225,000
R43 · FY2018 · GM
An Epitope-Focused Pediatric RSV Vaccine$224,141
R43 · FY2016 · AI